Article
The Biology of Hypomorphic TP53 Variants and Implications for Clinical Management.
Clinical cancer research : an official journal of the American Association for Cancer Research - 14 Aug 2026
Moses Renyta, Powers Jacquelyn, Levine Alison S, Garber Judy E, MacFarland Suzanne P, Rana Huma Q, Murphy Maureen E, Maxwell Kara N
Abstract excerpt
In individuals with classic Li-Fraumeni syndrome (LFS) due to a loss-of-function pathogenic germline variant in TP53, loss of p53 tumor suppressive function leads to a high risk of childhood cancers such as sarcomas, adrenal cortical carcinomas, brain tumors, and leukemia. In adults with classic LFS, in addition to the classical malignancies, breast cancers and other cancers develop at earlier ages of onset...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
